To further verify the cellular identity of our cultures, we used deep high-throughput RNA sequencing from two lines derived from two patients with ALS-causing VCP gene mutations (p.R155C and p.R191Q) and two healthy control lines (Supplemental Table S1; Ziff et al. 2021). The gene discussed is VCP; the disease is amyotrophic lateral sclerosis.